Ah0003 50522

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Alzheimer disease

Closed trials

• Completed

  A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

  NCT04867616· Phase 2· UCB Biopharma SRL· Source